[ANALYSIS OF THE USE OF ANTIBIOTIC THERAPY IN PREMATURE INFANTS, TAKING INTO ACCOUNT THE CHARACTERISTICS OF THE

N Kobeshavidze1, D Chikviladze2, Kh Gachechiladze2

  • 11LTD "Imedis Clinica", Tbilisi, Georgia.

Georgian Medical News
|March 7, 2020
PubMed

Insights

This study analyzed microbial resistance in premature infants, finding gram-positive bacteria predominated. Antibiotic use varied significantly, impacting microbial sensitivity during the neonatal period.

Area of Science:

  • Neonatal microbiology
  • Antibiotic resistance
  • Microbial ecology in infants

Background:

  • Premature infants face unique microbial challenges.
  • Microbial colonization of respiratory, urinary, and colon tracts is critical.
  • Understanding early-life microbial dynamics is essential for health outcomes.

Purpose of the Study:

  • To determine the antibiotic sensitivity/resistance patterns of microbial strains in premature infants.
  • To assess the influence of hospitalization and antibiotic therapy duration on microbial resistance.
  • To characterize microbial flora in key neonatal biotopes.

Main Methods:

  • Isolation and identification of 677 microbial strains from respiratory, urinary, and colon biotopes.
  • Antibiotic sensitivity/resistance testing using disc diffusion and dilution methods.
  • Analysis of antibiotic therapy regimens and duration in hospitalized newborns.

Main Results:

  • Gram-positive flora (386 strains) predominated over gram-negative flora (291 strains).
  • Antibiotic therapy duration ranged from 19 to 22 days, with 4-17 different regimens used.
  • Carbapenems, Glycopeptide, third-generation Cephalosporins, and Aminoglycosides were frequently administered.

Conclusions:

  • Neonatal microbial colonization patterns show a predominance of gram-positive bacteria.
  • Prolonged and varied antibiotic use in premature infants influences microbial resistance.
  • Further research is needed to optimize antibiotic stewardship in neonatal intensive care units.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
156
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
198
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
185
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
226